Clinical Trial Update: Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenabasum for cystic fibrosis has completed; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• lenabasum (lenabasum)

Snippet

Sponsor: Corbus Pharmaceuticals Inc. | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2023-01-18